SHENYANG, China, July 1 /Xinhua-PRNewswire-FirstCall/ -- 3SBio Inc. (NASDAQ:SSRX), a leading biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China, today announced that it has filed with the SEC an annual report on Form 20-F for the year ended December 31, 2007. Copies of the report are available for download under the Investors page on the Company's website at http://bbs.3sbio.com/en/News/ShowInfo_n16.aspx?ID=30 .
About 3SBio Inc.
3SBio Inc. is a leading, fully integrated biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, primarily in China.
For more information, please visit 3SBio on the web at: http://www.3sbio.com/ .
For more information, please contact: Investor Contact:
Kevin Teo, CFO
3SBio Inc. Tel: +86-24-2581-1820 Investor Relations (US):
Mahmoud Siddig
Taylor Rafferty
Tel: +1-212-889-4350 Investor Relations (HK):
Ruby Yim
Taylor Rafferty
Tel: +852-3196-3712 Media Contact:
Jason Marshall
Taylor Rafferty
Tel: +1-212-889-4350
DATASOURCE: 3SBio Inc.
CONTACT: Kevin Teo, CFO of 3SBio Inc., +86-24-2581-1820; or Investor Relations (US), Mahmoud Siddig, +1-212-889-4350, or Investor Relations (HK), Ruby Yim, +852-3196-3712, or Media Contact, Jason Marshall, +1-212-889-4350, all of Taylor Rafferty for 3SBio Inc.
Web site: http://www.3sbio.com/ http://bbs.3sbio.com/en/News/ShowInfo_n16.aspx?ID=30
|